Adamastor Bioservices
Adamastor Bioservices is a Magenta, Italy-based CRO providing molecular binding assays — RT-CBA (LigandTracer) and SPR (Biacore) — plus consulting and Ridgeview Instruments distribution to pharmaceutical and biotech companies developing therapeutics for neurodegenerative, inflammatory, and infectious diseases.
- Company typePrivate
- Founded2024
- HeadquartersMagenta, Italy
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Adamastor Bioservices does
Adamastor Bioservices Srl is a privately held Italian biophysics services company headquartered in Magenta that delivers molecular binding assays, real-time cell-binding assays (RT-CBA), and Surface Plasmon Resonance (SPR) analyses to pharmaceutical and biotechnology clients developing therapeutics for neurodegenerative, inflammatory, and infectious diseases. Its core technical stack combines the LigandTracer Green platform for label-free, real-time monitoring of molecular interactions on live cells — capturing binding kinetics, off-rates, specificity, dimerization, and internalization under physiological conditions — with the Biacore T200 SPR system for label-free kinetic profiling of small molecule-protein, protein-protein, antibody-antigen, nucleic acid, lipid, and whole-cell interactions. The company holds official Ridgeview Instruments (LigandTracer) distribution rights for Switzerland and Italy, and supports both in-house assay execution and external instrument demonstrations.
The business operates a professional services and consulting model. Revenue is generated through three streams: fee-for-service biophysics assays (RT-CBA and SPR) validating binding capacity of drug candidates; consulting engagements covering assay design, optimization, data analysis, and technology acquisition support; and instrument sales and on-site demonstrations via the Ridgeview distribution agreement. Pricing is fully quote-based with no public list rates, and go-to-market is sales-led — driven by direct client engagement, website inquiries, email and phone outreach, and presence at industry events such as London Lab Live and the Festival of Biologics in Basel.
The company is founder-led, with João Encarnação (PhD) as CEO and Giulia Opassi (PharmD, PhD) as CSO, supported by an advisor and team members with R&D backgrounds at the leading SPR and RT-CBA instrument manufacturers. Founded in September 2024, with the lab operational by October 2024 and an independent Magenta facility opened in August 2025, Adamastor has rapidly extended its footprint through the ITCH-AMP Interreg Italy-Switzerland consortium on antimicrobial resistance (2025-2027), a strategic collaboration with Swiss proteomics firm DTI-Tech, and French CIR (Crédit d'Impôt Recherche) certification enabling French clients to claim research tax credits on collaborative projects.
Adamastor Bioservices firmographics
Firmographics- Name
- Adamastor Bioservices
- Legal name
- Adamastor Bioservices Srl
- Website
- https://adamastor-bioservices.com
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Adamastor Bioservices is a Magenta, Italy-based CRO providing molecular binding assays — RT-CBA (LigandTracer) and SPR (Biacore) — plus consulting and Ridgeview Instruments distribution to pharmaceutical and biotech companies developing therapeutics for neurodegenerative, inflammatory, and infectious diseases.
- Ownership category
- akta.pro rank
Adamastor Bioservices industry classification
Industry- Product category
- Biophysics Assay Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD)
- akta.pro secondary industries
- Cell-Based & Potency Assays (Bioassays) (HLAGADAH), Proteomics & Biomarker Analytical Testing (HLAGADAG)
Keywords
Where Adamastor Bioservices is headquartered
LocationHeadquarters
- HQ city
- Magenta
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
Adamastor Bioservices business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Biophysics Assay Services: Providing state-of-the-art and innovative biophysics assays including RT-CBA and SPR to validate binding capacity of newly developed molecules against specific targets or living cells for pharmaceutical and biotech clients.
- SPR and LigandTracer Consulting: Expert consulting services for development of SPR assays and LigandTracer assays, including assay design, optimization, data analysis, and technology acquisition support.
- Instrument Distribution: As official distributor for Ridgeview Instruments in Switzerland and Italy, generating revenue through instrument sales and on-site demonstrations.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Adamastor Bioservices product offering
Product offeringCore offering
Adamastor Bioservices is a biophysics contract research organization that provides molecular binding assay services — specifically Real-time Cell-Binding Assays (RT-CBA) and Surface Plasmon Resonance (SPR) — to pharmaceutical and biotechnology companies. The services characterize kinetic, affinity, and concentration properties of molecular interactions to support drug development, and are complemented by consulting and data interpretation support.
Product overview
Adamastor Bioservices provides a portfolio of three integrated biophysics assay services for pharmaceutical and biotech companies: RT-CBA (Real-time Cell-Binding Assays) using LigandTracer Green for live cell interaction studies; SPR (Surface Plasmon Resonance) using Biacore T200 for label-free kinetic analysis; and Consulting services for assay development and Ridgeview Instruments distribution. The company specializes in supporting drug development for neurodegenerative, inflammatory, and infectious diseases.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Real-time monitoring enables correlation of binding kinetics with functional outcomes such as cellular signaling response
- +1 more outcomes
Companies that use Adamastor Bioservices
Customer profileSegments2 records
Ideal customer profiles2 records
Adamastor Bioservices technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Adamastor Bioservices partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- DTI-TechcoreStrategic collaboration with Swiss company specializing in drug target identification through advanced proteomics. Partnership integrates target identification with quantitative binding characterization, providing a complete workflow from target discovery to biophysical validation.
- Interreg ITCH-AMP ConsortiumcoreProject under Interreg Italy-Switzerland programme addressing antimicrobial resistance (AMR) through multidisciplinary approach combining phage therapy, engineered proteins, binding kinetics studies, and AI-driven methodologies. Consortium includes University of Eastern Piedmont, Precise Health SA, BioArk, and HES-SO Valais-Wallis (2025-2027).
- Ridgeview InstrumentscoreOfficial distributor for Ridgeview Instruments (LigandTracer technology) in Switzerland and Italy. Offers on-site demonstrations of state-of-the-art instruments, providing hands-on experience for researchers.
- University of Eastern Piedmont (UPO)coreAcademic partner in ITCH-AMP Interreg project and network member. Leading the consortium addressing antimicrobial resistance.
- Precise Health SAminorSwiss company partner in ITCH-AMP consortium for antimicrobial resistance research.
- BioArkminorAssociated partner in ITCH-AMP Interreg project consortium.
- HES-SO Valais-WallisminorAssociated partner in ITCH-AMP Interreg project consortium (Swiss university of applied sciences).
Scale indicators2 records
Recent moves7 records
Expansion highlights5 records
Adamastor Bioservices competitors and assessment
Company assessmentBroad incumbents
- Eurofins Scientific: Global leader in bioanalytical and biopharma product testing services, including binding assays and characterization. Overlaps with Adamastor's SPR/RT-CBA service offering but as part of a vastly broader testing portfolio serving global pharma.
- Sartorius: Provides bioprocessing and bioanalytics instruments (including Octet SPR alternative) and related services. Competes with Adamastor's instrument supply chain and adjacent biophysics services for pharma R&D.
- Cytiva (Biacore): Manufacturer of the Biacore T200 SPR platform that Adamastor uses. Represents both a key supplier and an indirect competitor through Cytiva's own biopharma service collaborations.
- Charles River Laboratories: Major CRO offering drug discovery and development services including biophysical characterization. Competes with Adamastor for pharma binding kinetics work but at much greater scale and with bundled service offerings.
Direct peers
- Proteros: Specialty CRO offering structure-based drug discovery services including biophysics-driven lead characterization. Closely comparable to Adamastor's biophysics-focused service model for pharma and biotech discovery programs.
- Creoptix (Wyatt Technology): SPR instrument manufacturer and services provider (now part of Wyatt Technology). Directly competes with Adamastor's SPR service offering and represents an alternative vendor relationship for live kinetic analysis.
- Nicoya Lifesciences: Developer of Alto SPR instruments with associated services for biomolecular interaction analysis. Competes in the same kinetic profiling space as Adamastor's SPR service line.
- Crelux (Evotec): Biophysics-driven drug discovery CRO (now part of Evotec) offering protein production, SPR, and biophysical characterization. Highly comparable service model targeting European pharma and biotech discovery teams.
Emerging players
- DTI-Tech: Swiss company specializing in drug target identification via advanced proteomics. Adamastor's strategic partner and a partial overlap in the early drug discovery value chain.
- Nanion Technologies: German specialist in biophysics instrumentation (patch clamp, SPR variants) and related assay services. Comparable niche European biophysics tools and services provider.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Adamastor Bioservices social profiles
Digital presenceAdamastor Bioservices compliance and trust
Trust signalCompliance1 record
Adamastor Bioservices financial estimates
Financial estimateRevenue estimate
Valuation estimate
Adamastor Bioservices leadership team
Management profileNumber of profiles
Profiles7 records
Adamastor Bioservices funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Adamastor Bioservices M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Adamastor Bioservices
What does Adamastor Bioservices do?
Adamastor Bioservices is a biophysics contract research organization that provides molecular binding assay services — specifically Real-time Cell-Binding Assays (RT-CBA) and Surface Plasmon Resonance (SPR) — to pharmaceutical and biotechnology companies. The services characterize kinetic, affinity, and concentration properties of molecular interactions to support drug development, and are complemented by consulting and data interpretation support.
Is Adamastor Bioservices a public or private company?
Adamastor Bioservices is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Adamastor Bioservices founded?
Adamastor Bioservices was founded in 2024. It employs 1 to 10 people.
Where is Adamastor Bioservices based?
Adamastor Bioservices is headquartered in Magenta, Italy, in the Europe region.
How does Adamastor Bioservices make money?
Three revenue lines are on record. Biophysics Assay Services are the primary driver. The others are SPR and LigandTracer Consulting and instrument Distribution.
Who are Adamastor Bioservices's main competitors?
Broad incumbents on record are Eurofins Scientific, Sartorius, Cytiva (Biacore) and Charles River Laboratories. Direct peers are Proteros, Creoptix (Wyatt Technology), Nicoya Lifesciences and Crelux (Evotec). Emerging players are DTI-Tech and Nanion Technologies.
Does Adamastor Bioservices have an API?
No public API is recorded for Adamastor Bioservices.
What industry is Adamastor Bioservices in?
Adamastor Bioservices's product category is Biophysics Assay Services. Its primary akta.pro industry code is HLAGAAAD, Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity), with a secondary code of HLAGADAH, Cell-Based & Potency Assays (Bioassays). Its NAICS code is 541714 and its SIC code is 8731.